Ellence Injection, Solution
Product Images NDC 0009-5091

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Ellence (NDC 0009-5091). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmacia & Upjohn Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Ellence 01)

Figure 1 (Ellence 01)
FDA Label Image

Figure 2 (Ellence 02)

Figure 2 (Ellence 02)
FDA Label Image

Chemical Structure (Ellence 03)

Chemical Structure (Ellence 03)
FDA Label Image

Figure 3 (Ellence 04)

Figure 3 (Ellence 04)
Not available.*
FDA Label Image

Figure 4 (Ellence 05)

Figure 4 (Ellence 05)
FDA Label Image

Figure 5 (Ellence 06)

Figure 5 (Ellence 06)
FDA Label Image

Figure 6 (Ellence 07)

Figure 6 (Ellence 07)
FDA Label Image

Logo (Ellence 08)

Logo (Ellence 08)
This is a product label for injectables distributed by Pharmacia & Upjohn Co, a division of Pfizer Inc, located in New York City.*
FDA Label Image

Principal Display Panel (50 mg/25 mL Vial Label)

Principal Display Panel (50 mg/25 mL Vial Label)
This is a pharmaceutical product called Ellence, which is an injectable containing epirubicin hydrochloride for intravenous use only. It is available in a single-dose vial and should be kept refrigerated between 2-8°C. This product is manufactured in Australia and distributed by Pharmacia & Upjohn Co. Further details on dosage and use can be found in the accompanying prescribing information.*
FDA Label Image

Principal Display Panel (50 mg/25 mL Vial Carton)

Principal Display Panel (50 mg/25 mL Vial Carton)
This is a cautionary label for a cytotoxic agent that is required to be refrigerated and protected from light. The vial contains epirubicin hydrochloride, sodium chloride, and water for injection, and has a pH of 3.0. The dosage and usage instructions should be found in the accompanying prescribing information. This text does not provide the prescription information.*
FDA Label Image

Principal Display Panel (200 mg/100 mL Vial Label)

Principal Display Panel (200 mg/100 mL Vial Label)
This is a description of a medication called Ellence (epirubicin hydrochloride injection) indicated for intravenous use only. The medication is stored refrigerated between 2°C to 8°C and should not be frozen to be used as injectable product. It should be protected from light and discarded after a single use. The text also provides information on dosage, usage, and prescribing information. The product is distributed by Pharmacia & Upjohn Co Division of Pfizer Inc in New York, NY. The lot number of this medication is PAN72290.*
FDA Label Image

Principal Display Panel (200 mg/100 mL Vial Carton)

Principal Display Panel (200 mg/100 mL Vial Carton)
This is a caution regarding a cytotoxic agent that needs to be stored in a refrigerated environment. It is also advised to protect the agent from light and not to freeze. The solution has no preservatives and comes in a single-dose vial, so the unused portion should be discarded. The solution contains epirubicin hydrochloride, sodium chloride, and water for injection. The pH of the solution has been adjusted to 3.0 with hydrochloric acid and/or sodium hydroxide. The accompanying prescribing information should be consulted for dosage and use. It is for intravenous use only. The agent is good for a 100mL dose and has 200 mg of epirubicin hydrochloride per 100mL of solution. It is distributed by Pfizer Inc. and is made in Australia.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.